B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children
Background SLE is likely triggered by gene–environment interactions. We have shown that most SLE-associated haplotypes encompass genomic regions enriched for epigenetic marks associated with enhancer function in lymphocytes, suggesting genetic risk is exerted through altered gene regulation. Data re...
Main Authors: | Betty Diamond, Joyce Hui-Yuen, Kaiyu Jiang, Susan Malkiel, Barbara Anne Eberhard, Heather Walters, James Jarvis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/10/1/e000921.full |
Similar Items
-
301 The Lupus Risk Index (LRI) as a biomarker in patients with lupus nephritis
by: Cynthia Aranow, et al.
Published: (2022-12-01) -
Recirculation of naive T lymphocytes
by: Jandrić-Kočić Marijana
Published: (2022-01-01) -
HMGB1 in Systemic Lupus Erythematosus
by: Tianye Liu, et al.
Published: (2020-05-01) -
12 Management of paediatric lupus
by: Elizabeth Ang
Published: (2023-09-01) -
13 Management of paediatric lupus
by: Joan Calzada-Hernández
Published: (2023-09-01)